Xiaolong Yan

Xiaolong Yan

Auto-generated profile, based on publicly available information

Xiaolong Yan

Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2002
Verified
Book Chapter
Closed access
PDF file
HLHong Liao
Hong Liao
GRGerardo Rubio
Gerardo Rubio
XYXiaolong Yan
Xiaolong Yan
ACAiqin Cao
Aiqin Cao
KBKathleen M. Brown
Kathleen M. Brown
JLJonathan P. Lynch
Jonathan P. Lynch


17 September 2024 in Nutrition, Metabolism and Cardiovascular Diseases
Verified
Journal Article
Closed access
JWJing Wang
Jing Wang
TCtingting chen
tingting chen
WZWenmin Zhu
Wenmin Zhu
ZSZiwei Shi
Ziwei Shi
XYXiaolong Yan
Xiaolong Yan
QWQi Wang
Qi Wang

25 April 2024 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Closed access
JWJing Wang
Jing Wang
QWQi Wang
Qi Wang
ZSZiwei Shi
Ziwei Shi
XYXiaolong Yan
Xiaolong Yan
ALAndrew Lei
Andrew Lei
WZWenmin Zhu
Wenmin Zhu
Background: Previous studies usually focused on the separate association of metabolism or genetic factors with lung cancer risk and have largely ignored their combined effect. We aimed to examine the associations between serum lipid levels, genetic risk, and lung cancer risk. Methods: A total of 426,524 participants of the UK Biobank were included. The Cox proportional hazards models and restricted cubic splines were performed to assess the association between serum lipid and lung cancer risk. Polygenic risk score (PRS) was constructed to assess its joint effect and interaction with serum lipid on lung cancer risk. Results: Higher level of apolipoprotein A was significantly correlated with lower lung cancer risk. An inverse-J-shaped relationship between high-density lipoprotein (HDL) and incident lung cancer was found. Individuals with low total cholesterol, HDL, low-density lipoprotein (LDL), apolipoprotein A, and apolipoprotein B, combined with high PRS, showed significantly elevated lung cancer risks. Compared to those with low PRS and low triglycerides, participants with high PRS and elevated triglyceride levels had a notably higher risk. The interaction effect of high PRS and low LDL [relative excess risk due to the interaction (RERI): 0.25, 95% confidence interval, 0.04–0.46], as well as the interaction effect of high PRS and low apolipoprotein B (RERI: 0.28, 95% confidence interval, 0.07–0.48), were both greater than the sum of their individual effects on lung cancer risk. Conclusions: Serum lipids were associated with lung cancer risk. LDL or apolipoprotein B interacting with genetic risk may affect lung cancer risk. Impact: Our findings emphasize the need for individuals with heightened genetic risk should pay more attention to their lipid levels to reduce lung cancer risk.

1 July 2024
Verified
Other
Open access
JWJing Wang
Jing Wang
QWQi Wang
Qi Wang
ZSZiwei Shi
Ziwei Shi
XYXiaolong Yan
Xiaolong Yan
ALAndrew Lei
Andrew Lei
WZWenmin Zhu
Wenmin Zhu
Supplementary Figure S1 shows the correlation matrix for serum lipid levels.

1 July 2024
Verified
Other
Open access
JWJing Wang
Jing Wang
QWQi Wang
Qi Wang
ZSZiwei Shi
Ziwei Shi
XYXiaolong Yan
Xiaolong Yan
ALAndrew Lei
Andrew Lei
WZWenmin Zhu
Wenmin Zhu
Supplementary Table S4 shows the results of sensitivity analysis restricted to participants with complete covariates.